91�Ʋ���

91�Ʋ���'s Wenhan Zhu, PhD, has received a three-year award from the G. Harold and Leila Y. Mathers Foundation to support his research that aims to answer a fundamental question about bacterial physiology and engineer probiotics to improve gut inflammatory diseases.

91�Ʋ��� was part of a multi-center team that resurrected a “dead antibody” to reveal the mysteries of cytochrome c, a versatile protein that is an essential part of the cell’s energy-generating capacity, and of life itself.

A 91�Ʋ��� study found that prostate cancer polygenic risk score has limited utility for enhancing prostate cancer screening.

91�Ʋ���ers in the labs of Laurie Cutting and Bennett Landman recently published a study in Magnetic Resonance Imaging exploring a new tool for imaging the brains of neurofibromatosis type 1 patients and its significance in assessing their symptoms.  Read More

91�Ʋ��� University computer scientist Ipek Oguz aims to expand a medical image analysis tool she developed that tracks placental growth in relation to fetal growth and could better identify at-risk pregnancies.

A 91�Ʋ��� study concluded that RSV’s ability to mutate rapidly to escape detection by the body’s immune system makes it more challenging to design and develop vaccines that can stop it from spreading.

Chuck Sanders, Aileen M. Lange and Annie Mary Lyle Chair of Cardiovascular 91�Ʋ��� and professor of biochemistry and medicine, has recently been promoted from associate dean for research to vice dean of the 91�Ʋ��� School of Medicine Basic Sciences.

A clinical patient encounter led two Medical Innovators Development Program students to develop a potentially life-saving technology through an industry immersion experience with GE HealthCare.

91�Ʋ��� research found that sleep irregularity — chronically disrupted sleep and highly variable sleep durations night after night — may increase the risk for atherosclerosis.

A collaborative team at 91�Ʋ��� is transforming the diagnosis and treatment of lipedema, a debilitating, abnormal deposition of fatty tissue that afflicts an estimated 17 million women in the United States.

91�Ʋ��� researchers have developed a new method to analyze mutations in blood stem cells that can trigger explosive, clonal expansions of abnormal cells.

The 91�Ʋ��� School of Nursing has been approved for a $250,000 award that will support identifying and disseminating strategies for overcoming barriers to patient- and family-centered comparative effectiveness research with patients who are critically ill and hospitalized in an intensive care unit setting.

Growing worries among Grundy County, Tennessee, residents about cancer outbreaks within families, churches and neighborhoods have propelled a community partnership drawing on 91�Ʋ��� University’s strengths to develop environmental and health self-assessment tools. Read More

Mikail Rubinov has been awarded $600,000 from the National Science Foundation to develop new computational methods for analysis of large-scale brain activity data.

An international consortium co-led by 91�Ʋ���'s Rubén Martínez-Barricarte has discovered a new genetic disorder that causes immunodeficiency and profound susceptibility to opportunistic infections including a life-threatening fungal pneumonia. 

Neil Osheroff and his lab provide foundational research for new Urinary Tract Infection antibiotic. UTIs affect half of all women. Read More

91�Ʋ��� School of Nursing has received a $3 million Health Resources and Services Administration grant from the Department of Health and Human Services to create a training program, standardized set of competencies and certification for community health workers in Tennessee.

The laboratories of Brian Bachmann and Jonathan Irish have developed a method to discover new small molecules that may kill cancer cells by working through the body’s immune system. Read More

For his work on zoonotic threat mitigation, Lars Plate was awarded $50,000 from the 91�Ʋ��� Corporation for Science Advancement and the U.S. Department of Agriculture. Read More

A company co-founded by 91�Ʋ��� mechanical engineering professor Robert J. Webster III has received a breakthrough device designation from the U.S. Food and Drug Administration that could open the door for new diagnostic and therapeutic applications of flexible endoscopy.